Kyle Haug is Director of AIkido Pharma Inc.. Currently has a direct ownership of 24,409 shares of AIKI, which is worth approximately $92,754. The most recent transaction as insider was on Feb 10, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K
n/a 3M change
n/a 12M change
Total Value Held $92,754

Kyle Haug Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2025
BUY
Grant, award, or other acquisition
-
10,000 Added 29.06%
24,409 Common Stock
Feb 10 2025
BUY
Open market or private purchase
-
14,409 Added 50.0%
14,409 Common Stock
KH

Kyle Haug

Director
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Track Activities on AIKI